未登录 分享 收藏
分享 收藏
分享 收藏
分享 收藏
Effect of plasmapheresis versus standard medical treatment in patients with hypertriglyceridemia-associated acute pancreatitis complicated by early organ failure (PERFORM-R): Study design and rationale of a multicenter, pragmatic, registry-based randomized controlled trial 与标准药物治疗相比,血浆置换对高甘油三酯相关性急性胰腺炎早期器官衰竭并发症患者的疗效(PERFORM-R):一项多中心、务实、基于注册的随机对照试验的研究设计与原理 Zhou, Jing; Wang, Lanting; Chen, Tao; Li, Chao; Long, Yue; Zou, Xinsen; Dong, Zhouzhou; Sun, Yun; Zhang, Guoxiu; Zeng, Zhenguo; Li, Gang; Ye, Bo; Cao, Longxiang; Ke, Lu; Liu, Yuxiu; Tong, Zhihui; Li, Weiqin 分享 收藏
Triglyceride-lowering therapies in hypertriglyceridemia-associated acute pancreatitis in China: a multicentre prospective cohort study 中国高甘油三酯血症相关急性胰腺炎的降甘油三酯治疗: 一项多中心前瞻性队列研究 Zhou, Jing; Wang, Zuozheng; Liu, Qinghong; Cao, Longxiang; De-Madaria, Enrique; Capurso, Gabriele; Stoppe, Christian; Wu, Dong; Huang, Wei; Chen, Yingjie; Liu, Siyao; Hong, Donghuang; Sun, Yun; Zeng, Zhenguo; Qin, Kaixiu; Ni, Haibin; Sun, Yi; Long, Yue; Guo, Feng; Liu, Xiaofeng; Zheng, Xisheng; Zhang, Guoxiu; Zhang, Xiangcheng; Zhou, Kai; Chen, Yizhe; Jiao, Qinghai; Zou, Xinsen; Luo, Xiang; Li, Gang; Ye, Bo; Li, Chao; Wang, Lanting; Li, Shuai; Windsor, John; Liu, Yuxiu; Tong, Zhihui; Li, Weiqin; Ke, Lu 分享 收藏
Phase I/II ARROS-1 study of zidesamtinib (NVL-520) in ROS1 fusion-positive solid tumours I/II期ARROS-1研究:zidesamtinib(NVL-520)在ROS1融合阳性实体瘤中的应用 Besse, B.; Drilon, A. E.; Cho, B. C.; Camidge, D. R.; Neal, J.; Lin, C-C.; Liu, S. V.; Nagasaka, M.; Kao, S. C-H.; Felip, E.; Van der Wekken, A. J.; Lin, C. C.; Bauman, J. R.; Gadgeel, S.; Samant, M.; Shen, J.; Sun, Y.; Zhu, V. W.; Upadhyay, V. A.; Lin, J. J. 分享 收藏
分享 收藏
Droplet digital PCR improved the EGFR mutation diagnosis with pleural fluid samples in non-small-cell lung cancer patients 微滴式数字PCR提高非小细胞肺癌患者胸水标本EGFR突变诊断的价值 Li, Xiaoyan; Liu, Yi; Shi, Weiwei; Xu, Huayan; Hu, Haixu; Dong, Zhengwei; Zhu, Guanshan; Sun, Yun; Liu, Bing; Gao, Hongjun; Tang, Chuanhao; Liu, Xiaoqing 分享 收藏
Plasma EGFR T790M ctDNA status is associated with clinical outcome in advanced NSCLC patients with acquired EGFR-TKI resistance Zheng, D.; Ye, X.; Zhang, M. Z.; Sun, Y.; Wang, J. Y.; Ni, J.; Zhang, H. P.; Zhang, L.; Luo, J.; Zhang, J.; Tang, L.; Su, B.; Chen, G.; Zhu, G.; Gu, Y.; Xu, J. F. 分享 收藏
Recurrent amplification of MYC and TNFRSF11B in 8q24 is associated with poor survival in patients with gastric cancer Wang, Xiaohong; Liu, Yiqiang; Shao, Duanfang; Qian, Ziliang; Dong, Zhengwei; Sun, Yun; Xing, Xiaofang; Cheng, Xiaojing; Du, Hong; Hu, Ying; Li, Yingai; Li, Lin; Dong, Bin; Li, Ziyu; Wu, Aiwen; Wu, Xiaojiang; Bu, Zhaode; Zong, Xianglong; Zhu, Guanshan; Ji, Qunsheng; Wen, Xian-zi; Zhang, Lian-hai; Ji, Jia-fu 分享 收藏
分享 收藏